EUROBIO SCIENTIFIC obtains CE marking for its proprietary test for Covid-19 screening and detection of the Omicron and Delta variants
December 13, 2021 12:00 ET
|
Eurobio Scientific
Eurobio Scientific obtains CE marking for its proprietary test for Covid-19 screening and detection of the Omicron and Delta variants Routine COVID screening test simultaneously detecting the...
EUROBIO SCIENTIFIC LANCE LE PREMIER TEST PCR PERMETTANT EN UNE SEULE REACTION LE DEPISTAGE DU VIRUS DU SARS-COV-2 ET LA DETECTION DES VARIANTS DELTA ET OMICRON
November 30, 2021 11:45 ET
|
Eurobio Scientific
EUROBIO SCIENTIFIC LANCE LE PREMIER TEST PCR PERMETTANT EN UNE SEULE REACTION LE DEPISTAGE DU VIRUS DU SARS-COV-2 ET LA DETECTION DES VARIANTS DELTA ET OMICRON Test pour détecter la présence du...
Eurobio Scientific Launches the First Pcr Test Allowing Simultaneous Sars-Cov-2 Virus Screening and Detection of the Delta and Omicron Variants in a Single Reaction
November 30, 2021 11:45 ET
|
Eurobio Scientific
EUROBIO SCIENTIFIC LAUNCHES THE FIRST PCR TEST ALLOWING SIMULTANEOUS SARS-COV-2 VIRUS SCREENING AND DETECTION OF THE DELTA AND OMICRON VARIANTS IN A SINGLE REACTION Test to detect the presence of...
EUROBIO SCIENTIFIC EUROBIO SCIENTIFIC PREND UNE PARTICIPATION MINORITAIRE DANS LA START-UP USENSE, QUI DEVELOPPE UN DISPOSITIF MEDICAL IN VITRO PORTATIF D’ANALYSE URINAIRE
November 23, 2021 12:15 ET
|
Eurobio Scientific
EUROBIO SCIENTIFIC PREND UNE PARTICIPATION MINORITAIRE DANS LA START-UP USENSE, QUI DEVELOPPE UN DISPOSITIF MEDICAL IN VITRO PORTATIF D’ANALYSE URINAIRE Avec cet investissement, le Groupe renforce...
Eurobio Scientific Makes a Minority Investment in Usense, a Start-Up Developping a Mobile in Vitro Medical Device for Urianalysis
November 23, 2021 12:15 ET
|
Eurobio Scientific
EUROBIO SCIENTIFIC MAKES A MINORITY INVESTMENT IN USENSE, A START-UP DEVELOPPING A MOBILE IN VITRO MEDICAL DEVICE FOR URIANALYSIS With this investment, the Group strengthens its offer in point of...
EUROBIO SCIENTIFIC : RESULTATS SEMESTRIELS 2021
October 12, 2021 11:35 ET
|
Eurobio Scientific
RESULTATS SEMESTRIELS 2021 EBITDA +110% à 42,5 M€Trésorerie nette à 60,4 M€COVID accélérateur des activités historiques et du développement stratégique Paris, le 12 octobre 2021 – 17h35 Eurobio...
EUROBIO Scientific : 2021 HALF-YEAR EARNINGS
October 12, 2021 11:35 ET
|
Eurobio Scientific
2021 HALF-YEAR EARNINGS EBITDA up +110% to €42.5mNet cash of €60.4mCOVID accelerating the Group’s longstanding activities and strategic development Paris, October 12, 2021 – 5:35pm Eurobio...
EUROBIO SCIENTIFIC RECOIT UN PAIEMENT D’ETAPE DE 430 000 $ DE LA PART D’ALLERGAN
October 06, 2021 02:00 ET
|
Eurobio Scientific
EUROBIO SCIENTIFIC RECOIT UN PAIEMENT D’ÉTAPE DE 430 000 $ DE LA PART D’ALLERGAN Passage au stade clinique d'une molécule issue du partenariat historique Paris, le 6 octobre 2021 – 8h00 Eurobio...
Eurobio Scientific Receives a $430,000 Milestone Payment From Allergan
October 06, 2021 02:00 ET
|
Eurobio Scientific
EUROBIO SCIENTIFIC RECEIVES A $430,000 MILESTONE PAYMENT FROM ALLERGAN Transition to clinical stage of a molecule derived from the former collaboration Paris, October 6, 2021 – 8:00 am Eurobio...
Eurobio Scientific: FIRST HALF TURNOVER REACHES € 95.7 MILLION, A 54% INCREASE
July 26, 2021 11:45 ET
|
Eurobio Scientific
FIRST HALF TURNOVER REACHES € 95.7 MILLION, A 54% INCREASE Strong growth in traditional activities excluding COVID : + 31% at € 40.9 millionExtension of the installed instrument parkContinuation of...